Albert David Limited (ALBERTDAVD.NS)
INR 791.6
(2.14%)
INR 791.6
(2.14%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 436.12 Million INR | -13.95% |
| 2022 | 506.82 Million INR | 29.36% |
| 2021 | 391.79 Million INR | 9.6% |
| 2020 | 357.48 Million INR | -16.33% |
| 2019 | 427.22 Million INR | -3.03% |
| 2018 | 440.57 Million INR | 1.97% |
| 2017 | 432.06 Million INR | -14.71% |
| 2016 | 506.56 Million INR | 4.35% |
| 2015 | 485.44 Million INR | -6.89% |
| 2014 | 521.36 Million INR | 20.9% |
| 2013 | 431.23 Million INR | 1.32% |
| 2012 | 425.62 Million INR | 5.75% |
| 2011 | 402.46 Million INR | 16.02% |
| 2010 | 346.87 Million INR | 10.28% |
| 2009 | 314.55 Million INR | -7.84% |
| 2008 | 341.29 Million INR | -8.54% |
| 2007 | 373.16 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 397.97 Million INR | 0.0% |
| 2023 Q4 | 436.12 Million INR | 0.0% |
| 2023 FY | 436.12 Million INR | -13.95% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 506.82 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 506.82 Million INR | 29.36% |
| 2022 Q2 | 372.95 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 303.13 Million INR | 0.0% |
| 2021 Q4 | 391.79 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 391.79 Million INR | 9.6% |
| 2020 Q2 | 334.05 Million INR | 0.0% |
| 2020 Q4 | 357.48 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 357.48 Million INR | -16.33% |
| 2019 Q2 | 364.05 Million INR | 0.0% |
| 2019 FY | 427.22 Million INR | -3.03% |
| 2019 Q4 | 427.22 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 440.57 Million INR | 0.0% |
| 2018 FY | 440.57 Million INR | 1.97% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 400.35 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 432.06 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 432.06 Million INR | -14.71% |
| 2017 Q2 | 389.5 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 506.56 Million INR | 4.35% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 506.56 Million INR | 0.0% |
| 2016 Q2 | 338.21 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 485.44 Million INR | 0.0% |
| 2015 FY | 485.44 Million INR | -6.89% |
| 2015 Q2 | 476.61 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 403.19 Million INR | 0.0% |
| 2014 FY | 521.36 Million INR | 20.9% |
| 2014 Q4 | 521.36 Million INR | 0.0% |
| 2013 Q2 | 392.42 Million INR | 0.0% |
| 2013 Q4 | 431.23 Million INR | 0.0% |
| 2013 FY | 431.23 Million INR | 1.32% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 425.62 Million INR | 5.75% |
| 2012 Q4 | 425.62 Million INR | 0.0% |
| 2012 Q2 | 359.73 Million INR | 0.0% |
| 2011 FY | 402.46 Million INR | 16.02% |
| 2011 Q4 | 402.46 Million INR | 0.0% |
| 2010 FY | 346.87 Million INR | 10.28% |
| 2009 FY | 314.55 Million INR | -7.84% |
| 2008 FY | 341.29 Million INR | -8.54% |
| 2007 FY | 373.16 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 97.346% |
| Hester Biosciences Limited | 755.81 Million INR | 42.298% |
| Aarti Drugs Limited | 4.85 Billion INR | 91.024% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 93.216% |
| Alembic Limited | 113.4 Million INR | -284.586% |
| Alkem Laboratories Limited | 26.61 Billion INR | 98.361% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -47.13% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 69.722% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -1610.48% |
| Brooks Laboratories Limited | 96.1 Million INR | -353.782% |
| Eris Lifesciences Limited | 1.89 Billion INR | 76.929% |
| FDC Limited | 3.88 Billion INR | 88.785% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 93.457% |
| Gufic Biosciences Limited | 2 Billion INR | 78.246% |
| Hikal Limited | 3.03 Billion INR | 85.641% |
| Ind-Swift Limited | 640.91 Million INR | 31.953% |
| Innova Captab Limited | 1.44 Billion INR | 69.717% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 89.734% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -190.805% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 96.618% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 43.484% |
| Lupin Limited | 49.53 Billion INR | 99.12% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 64.726% |
| Medico Remedies Limited | 163.37 Million INR | -166.95% |
| Morepen Laboratories Limited | 2.48 Billion INR | 82.457% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 93.85% |
| Orchid Pharma Limited | 2.64 Billion INR | 83.494% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 60.029% |
| RPG Life Sciences Limited | 1.01 Billion INR | 56.82% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -993.583% |
| Sigachi Industries Limited | 707.2 Million INR | 38.332% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 87.875% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 81.136% |
| Themis Medicare Limited | 705.74 Million INR | 38.204% |
| Unichem Laboratories Limited | 7.04 Billion INR | 93.811% |
| Vaishali Pharma Limited | 3.79 Million INR | -11385.936% |
| Wanbury Limited | 360.23 Million INR | -21.067% |
| Windlas Biotech Limited | 621.89 Million INR | 29.872% |
| ZIM Laboratories Limited | 812.62 Million INR | 46.332% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -317.033% |
| Ipca Laboratories Limited | 24.71 Billion INR | 98.235% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.558% |
| Venus Remedies Limited | 1.21 Billion INR | 64.161% |
| Sakar Healthcare Limited | 277.32 Million INR | -57.261% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.555% |
| Divi's Laboratories Limited | 31.84 Billion INR | 98.63% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 80.862% |
| Mankind Pharma Limited | 15.53 Billion INR | 97.193% |
| Sequent Scientific Limited | 3.46 Billion INR | 87.404% |
| Laurus Labs Limited | 18.45 Billion INR | 97.637% |
| Neuland Laboratories Limited | 3.5 Billion INR | 87.554% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 91.321% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 98.265% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 98.733% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -50.882% |
| Wockhardt Limited | 6.4 Billion INR | 93.186% |
| Bal Pharma Limited | 878.11 Million INR | 50.334% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.314% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 63.18% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -944.101% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 87.987% |
| Shilpa Medicare Limited | 3.44 Billion INR | 87.356% |
| Valiant Laboratories Limited | 100.15 Million INR | -335.45% |
| Ajanta Pharma Limited | 8.28 Billion INR | 94.735% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -25.771% |
| Granules India Limited | 13 Billion INR | 96.647% |
| Medicamen Biotech Limited | 593.75 Million INR | 26.548% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -106.874% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 98.086% |
| NATCO Pharma Limited | 7 Billion INR | 93.774% |
| Suven Life Sciences Limited | 7.08 Million INR | -6055.554% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -345.185% |
| Strides Pharma Science Limited | 11.26 Billion INR | 96.128% |
| Indoco Remedies Limited | 3.53 Billion INR | 87.647% |
| Alpa Laboratories Limited | 136.65 Million INR | -219.145% |
| Lasa Supergenerics Limited | 190.43 Million INR | -129.014% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -2848.357% |